ICU Medical, Inc. (ICUI)
- Previous Close
96.38 - Open
95.91 - Bid 98.56 x 100
- Ask 99.01 x 100
- Day's Range
95.47 - 99.53 - 52 Week Range
78.28 - 212.43 - Volume
72,777 - Avg. Volume
250,748 - Market Cap (intraday)
2.408B - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
-- - EPS (TTM)
-1.23 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
136.00
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
www.icumed.com14,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ICUI
Performance Overview: ICUI
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ICUI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ICUI
Valuation Measures
Market Cap
2.35B
Enterprise Value
3.80B
Trailing P/E
--
Forward P/E
20.28
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.03
Price/Book (mrq)
1.11
Enterprise Value/Revenue
1.68
Enterprise Value/EBITDA
15.00
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.31%
Return on Assets (ttm)
0.67%
Return on Equity (ttm)
-1.41%
Revenue (ttm)
2.26B
Net Income Avi to Common (ttm)
-29.66M
Diluted EPS (ttm)
-1.23
Balance Sheet and Cash Flow
Total Cash (mrq)
278.98M
Total Debt/Equity (mrq)
80.28%
Levered Free Cash Flow (ttm)
162.25M
Research Analysis: ICUI
Company Insights: ICUI
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: ICUI
ICUI: Lowering target price to $101.00
ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $101.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetICUI: Raising target price to $111.00
ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $111.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetICUI: Raising target price to $108.00
ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $108.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetICUI: Raising target price to $106.00
ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $106.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target